These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 7923178

  • 1. Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.
    Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M.
    Cancer Res; 1994 Oct 15; 54(20):5445-54. PubMed ID: 7923178
    [Abstract] [Full Text] [Related]

  • 2. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 15; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 3. Vitronectin binding to urokinase receptor in human breast cancer.
    Carriero MV, Del Vecchio S, Franco P, Potena MI, Chiaradonna F, Botti G, Stoppelli MP, Salvatore M.
    Clin Cancer Res; 1997 Aug 15; 3(8):1299-308. PubMed ID: 9815812
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
    Fox SB, Taylor M, Grøndahl-Hansen J, Kakolyris S, Gatter KC, Harris AL.
    J Pathol; 2001 Sep 15; 195(2):236-43. PubMed ID: 11592104
    [Abstract] [Full Text] [Related]

  • 5. Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue.
    Luther T, Magdolen V, Albrecht S, Kasper M, Riemer C, Kessler H, Graeff H, Müller M, Schmitt M.
    Am J Pathol; 1997 Apr 15; 150(4):1231-44. PubMed ID: 9094980
    [Abstract] [Full Text] [Related]

  • 6. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels.
    Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G.
    Cancer Res; 1993 Jul 01; 53(13):3198-206. PubMed ID: 7686450
    [Abstract] [Full Text] [Related]

  • 7. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues.
    Costantini V, Sidoni A, Deveglia R, Cazzato OA, Bellezza G, Ferri I, Bucciarelli E, Nenci GG.
    Cancer; 1996 Mar 15; 77(6):1079-88. PubMed ID: 8635127
    [Abstract] [Full Text] [Related]

  • 8. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B.
    Mol Hum Reprod; 2004 Sep 15; 10(9):655-63. PubMed ID: 15243126
    [Abstract] [Full Text] [Related]

  • 9. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
    Schaefer BM, Stark HJ, Fusenig NE, Todd RF, Kramer MD.
    Exp Cell Res; 1995 Oct 15; 220(2):415-23. PubMed ID: 7556451
    [Abstract] [Full Text] [Related]

  • 10. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A, Soeltl R, Lutz V, Wilhelm OG, Magdolen V, Rojo EE, Hantzopoulos PA, Graeff H, Gänsbacher B, Schmitt M.
    Cancer Gene Ther; 2000 Feb 15; 7(2):292-9. PubMed ID: 10770639
    [Abstract] [Full Text] [Related]

  • 11. Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma.
    Pyke C, Graem N, Ralfkiaer E, Rønne E, Høyer-Hansen G, Brünner N, Danø K.
    Cancer Res; 1993 Apr 15; 53(8):1911-5. PubMed ID: 8385573
    [Abstract] [Full Text] [Related]

  • 12. Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies.
    Floridon C, Nielsen O, Holund B, Sunde L, Westergaard JG, Thomsen SG, Teisner B.
    Placenta; 1999 Nov 15; 20(8):711-21. PubMed ID: 10527826
    [Abstract] [Full Text] [Related]

  • 13. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V, Schroeder J, Denkert C, Kristiansen G, Schnorr D, Loening SA, Jung K, Staack A.
    Oncol Rep; 2004 Oct 15; 12(4):909-13. PubMed ID: 15375521
    [Abstract] [Full Text] [Related]

  • 14. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors.
    Kumamoto H, Ooya K.
    J Oral Pathol Med; 2007 Sep 01; 36(8):488-94. PubMed ID: 17686008
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer.
    Grøndahl-Hansen J, Peters HA, van Putten WL, Look MP, Pappot H, Rønne E, Dano K, Klijn JG, Brünner N, Foekens JA.
    Clin Cancer Res; 1995 Oct 20; 1(10):1079-87. PubMed ID: 9815897
    [Abstract] [Full Text] [Related]

  • 18. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
    Gutova M, Najbauer J, Frank RT, Kendall SE, Gevorgyan A, Metz MZ, Guevorkian M, Edmiston M, Zhao D, Glackin CA, Kim SU, Aboody KS.
    Stem Cells; 2008 Jun 20; 26(6):1406-13. PubMed ID: 18403751
    [Abstract] [Full Text] [Related]

  • 19. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody.
    Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, Rao JS.
    Cancer Res; 1993 Sep 15; 53(18):4143-7. PubMed ID: 8395977
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer.
    Cozzi PJ, Wang J, Delprado W, Madigan MC, Fairy S, Russell PJ, Li Y.
    Hum Pathol; 2006 Nov 15; 37(11):1442-51. PubMed ID: 16949925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.